Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 129 of 129 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/16/23
End: 08/28/31
Due: 08/28/32
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 11/09/17
Due: 11/09/18
Phase: N/A
Priority: Normal
Start: 03/11/21
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 01/02/18
End: 03/31/25
Due: 03/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer | NCT05983276 | Loyola University | user2@example.com | None | 2023-11-16 | 2031-08-28 | 2032-08-28 | - | - | 2025-07-14 |
| Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) | NCT02186015 | Loyola University | user2@example.com | None | 2015-02-28 | 2017-11-09 | 2018-11-09 | - | - | 2025-07-14 |
| 5-day Defibrotide Treatment for Hepatic SOS/VOD | NCT04313036 | Loyola University | user2@example.com | None | 2021-03-11 | 2022-08-01 | 2023-08-01 | - | - | 2025-07-14 |
| Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition | NCT03378765 | Loyola University | user2@example.com | None | 2018-01-02 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |